HHS says it may revisit policy for anti-obesity drugsnews2025-04-07T20:08:01+00:00April 7th, 2025|Endpoints News|
Federal judge in Minnesota dismisses drugmakers’ 340B lawsuitsnews2025-04-07T19:58:23+00:00April 7th, 2025|Endpoints News|
PureTech rejects cash exit proposal from Nordic Capital after deal talksnews2025-04-07T19:39:12+00:00April 7th, 2025|Endpoints News|
Rare disease hub at CDER and CBER faces new reality with staff crunchnews2025-04-07T19:30:50+00:00April 7th, 2025|Endpoints News|
Drug tool and packaging makers to feel brunt of Trump tariffs, analysts saynews2025-04-07T17:05:24+00:00April 7th, 2025|Endpoints News|
RFK Jr. won’t testify before key Senate committee this week on HHS overhaulnews2025-04-07T16:21:58+00:00April 7th, 2025|Endpoints News|
Stock market melts down over Trump’s tariffs, and biotech’s pain keeps growingnews2025-04-07T15:46:11+00:00April 7th, 2025|Endpoints News|
Rhythm touts Phase 3 win for rare obesity drug in people with brain damagenews2025-04-07T11:00:53+00:00April 7th, 2025|Endpoints News|
GSK’s newest neuro pact is with ABL Bio, a Sanofi-partnered South Korean biotechnews2025-04-07T05:44:19+00:00April 7th, 2025|Endpoints News|
Trump administration leaves obesity coverage expansion out of new Medicare rulenews2025-04-04T21:10:38+00:00April 4th, 2025|Endpoints News|
